Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 2604-2610, May 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegrist, W.
Right arrow Articles by Eberle, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siegrist, W.
Right arrow Articles by Eberle, A. N.

Homologous and Heterologous Regulation of {alpha}-Melanocyte-stimulating Hormone Receptors in Human and Mouse Melanoma Cell Lines1

Walter Siegrist, Sibylla Stutz and Alex N. Eberle2

Laboratory of Endocrinology, Department of Research (ZLF), University Hospital and University Children's Hospital, Ch-4031 Basel, Switzerland

Specific high-affinity receptors for {alpha}-melanocyte-stimulating hormone ({alpha}-MSH) are found in variable abundance on many melanoma cell lines. We have examined melanocortin peptides and other factors for their ability to regulate the number of MSH receptors in eleven human and two mouse melanoma cell lines. MSH induced up-regulation of its own receptors in three human cell lines and down-regulation in six human and two mouse melanoma cell lines. No regulation was observed in two human lines. Scatchard analysis revealed modulation of the number of receptors per cell without any change in affinity. The concentrations inducing half-maximal response for up- and down-regulation were 1.6 nM and 0.23 nM, respectively. ACTH1–17 and [Nle4,D-Phe7]-{alpha}-MSH were more potent, whereas ACTH1–24, desacetyl-{alpha}-MSH, and [Nle4]-{alpha}-MSH were less potent in receptor up-regulation as compared to {alpha}-MSH. Down-regulation but not up-regulation could be fully mimicked by Gs-protein activation and partially by elevation of cellular cAMP. Combination of different agents which increase cAMP was found to be counterregulatory. TPA and retinoic acid generally down-regulated MSH receptors but had no effect on HBL cells. Several protein kinase inhibitors increased MSH binding in B16 cells. MSH-induced receptor down-regulation and melanin synthesis were most effectively antagonized by selective inhibitors of cAMP-dependent protein kinase in these cells. Taken together, MSH receptors on melanoma cells are both positively and negatively regulated. Whereas cAMP-dependent protein kinase activation seems to be involved in down-regulation, the mechanism responsible for up-regulation remains to be elucidated.

1 Presented in preliminary forms at the 9th International Congress of Endocrinology, August 30–September 5, 1992, Nice, France, and at the 5th Swiss Workshop of Methodology in Receptor Research, May 10–14, 1992, Agno-Lugano, Switzerland. This work was supported by the Swiss National Science Foundation (Grant 3100-25653), the Swiss Cancer League, and the Fund of the Department of Research.

2 To whom reprint requests should be addressed.

Received 12/ 3/93. Accepted 3/17/94.




This article has been cited by other articles:


Home page
JNMHome page
G. Ren, Z. Liu, Z. Miao, H. Liu, M. Subbarayan, F. T. Chin, L. Zhang, S. S. Gambhir, and Z. Cheng
PET of Malignant Melanoma Using 18F-Labeled Metallopeptides
J. Nucl. Med., November 1, 2009; 50(11): 1865 - 1872.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Cheng, L. Zhang, E. Graves, Z. Xiong, M. Dandekar, X. Chen, and S. S. Gambhir
Small-Animal PET of Melanocortin 1 Receptor Expression Using a 18F-Labeled {alpha}-Melanocyte-Stimulating Hormone Analog
J. Nucl. Med., June 1, 2007; 48(6): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. Schwarz, D. Renshaw, S. Kapas, and J. P Hinson
Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.
J. Endocrinol., August 1, 2006; 190(2): 505 - 514.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Beaumont, R. A. Newton, D. J. Smit, J. H. Leonard, J. L. Stow, and R. A. Sturm
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk
Hum. Mol. Genet., August 1, 2005; 14(15): 2145 - 2154.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Sanchez-Mas, L. A. Guillo, P. Zanna, C. Jimenez-Cervantes, and J. C. Garcia-Borron
Role of G Protein-Coupled Receptor Kinases in the Homologous Desensitization of the Human and Mouse Melanocortin 1 Receptors
Mol. Endocrinol., April 1, 2005; 19(4): 1035 - 1048.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Chen, Z. Cheng, N. K. Owen, T. J. Hoffman, Y. Miao, S. S. Jurisson, and T. P. Quinn
Evaluation of an 111In-DOTA-Rhenium Cyclized {alpha}-MSH Analog: A Novel Cyclic-Peptide Analog with Improved Tumor-Targeting Properties
J. Nucl. Med., December 1, 2001; 42(12): 1847 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chen, Z. Cheng, T. J. Hoffman, S. S. Jurisson, and T. P. Quinn
Melanoma-targeting Properties of 99mTechnetium-labeled Cyclic {{alpha}}-Melanocyte-stimulating Hormone Peptide Analogues
Cancer Res., October 1, 2000; 60(20): 5649 - 5658.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Adachi, E. Morii, D.-k. Kim, H. Ogihara, T. Jippo, A. Ito, Y.-M. Lee, and Y. Kitamura
Involvement of mi-Transcription Factor in Expression of {alpha}-Melanocyte-Stimulating Hormone Receptor in Cultured Mast Cells of Mice
J. Immunol., January 15, 2000; 164(2): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J Chluba-de Tapia, C Bagutti, R Cotti, and A. Eberle
Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene
J. Cell Sci., January 8, 1996; 109(8): 2023 - 2030.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.